Mark S. Tichenor - Concepedia

Author

Mark S. Tichenor

Scripps Research Institute ORCID

Also Known As

Mark S. Tichenor, Mark Tichenor

Publications

593

Citations

H-Index

Concepts

All Affiliations

Scripps Research Institute Janssen (United States)Johnson & Johnson (United States)

About

Mark S. Tichenor is an author at Scripps Research Institute specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	179
2	Biochemistry	5	5	241
3	Natural Sciences	4	4	200
4	Engineering	1	1	47
5	Biomolecular Engineering	1	1	47

Mark S. Tichenor

Publications

564

Citations

H-Index

Page 1

	Year	Citations
Total Synthesis, Structure Revision, and Absolute Configuration of (+)-Yatakemycin Mark S. Tichenor, David B. Kastrinsky, Dale L. Boger Journal of the American Chemical Society	2004	99
Yatakemycin: total synthesis, DNA alkylation, and biological properties Mark S. Tichenor, Dale L. Boger Natural Product Reports Structural AnaloguesMedicinal ChemistryBiosynthesisBioorganic ChemistryBiochemistry	2007	75
Asymmetric Total Synthesis of (+)- and <i>ent</i>-(−)-Yatakemycin and Duocarmycin SA: Evaluation of Yatakemycin Key Partial Structures and Its Unnatural Enantiomer Mark S. Tichenor, John D. Trzupek, David B. Kastrinsky, Journal of the American Chemical Society	2006	75
Preclinical Characterization of the FAAH Inhibitor JNJ-42165279 John M. Keith, W. M. Jones, Mark S. Tichenor, ACS Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryFaah Inhibitor Jnj-42165279BiochemistryMedicine	2015	59
Ruthenium-Mediated Cycloaromatization of Acyclic Enediynes and Dienynes at Ambient Temperature J. M. O’Connor, S.J. Friese, Mark S. Tichenor Journal of the American Chemical Society Inorganic ChemistryRoom TemperatureEngineeringHeterocyclicRuthenium Arene Complexes	2002	47
Systematic Exploration of the Structural Features of Yatakemycin Impacting DNA Alkylation and Biological Activity Mark S. Tichenor, Karen S. MacMillan, John D. Trzupek, Journal of the American Chemical Society Right SubunitsMolecular BiologyChemical BiologyEnzymatic ModificationPharmaceutical Chemistry	2007	41
Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate John M. Keith, Richard L. Apodaca, Mark S. Tichenor, ACS Medicinal Chemistry Letters BiochemistryOmega-3 Fatty AcidMedicinePhysiologyFatty Acid Ethanolamides	2012	41
Rational Design, Synthesis, and Evaluation of Key Analogues of CC-1065 and the Duocarmycins Mark S. Tichenor, Karen S. MacMillan, James S. Stover, Journal of the American Chemical Society	2007	36
Heteroaryl urea inhibitors of fatty acid amide hydrolase: Structure–mutagenicity relationships for arylamine metabolites Mark S. Tichenor, John M. Keith, W. M. Jones, Bioorganic & Medicinal Chemistry Letters Heteroaryl Urea InhibitorsStructure–mutagenicity RelationshipsBiochemistryNatural SciencesBiocatalysis	2012	25
Identification of highly selective SIK1/2 inhibitors that modulate innate immune activation and suppress intestinal inflammation Holger Babbe, Thomas B. Sundberg, Mark S. Tichenor, Proceedings of the National Academy of Sciences	2023	21

Page 1